Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NVNO
NVNO logo

NVNO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy enVVeno Medical Corp (NVNO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
12.700
1 Day change
17.76%
52 Week Range
196.700
Analysis Updated At
2026/02/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

enVVeno Medical Corp (NVNO) is not a strong buy for a beginner, long-term investor at this time. The lack of significant trading trends, poor financial performance, and absence of positive catalysts make it unsuitable for immediate investment. While the technical indicators are neutral, the company's financials and lack of growth do not support a compelling long-term investment case.

Technical Analysis

The MACD histogram is positive at 0.224, indicating mild bullish momentum, but it is contracting. RSI is neutral at 49.463, suggesting no strong overbought or oversold conditions. Moving averages are converging, indicating a lack of clear directional trend. Key support is at 8.99, and resistance is at 12.068. Overall, the technical indicators are neutral.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
8

Positive Catalysts

  • NULL identified. No recent news or significant trading trends from hedge funds or insiders.

Neutral/Negative Catalysts

  • The company's financial performance is weak, with net income and EPS showing significant declines year-over-year. No recent news or catalysts to drive investor sentiment positively.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth. Net income dropped by -19.55% YoY to -$4,539,000, and EPS declined by -35.88% YoY to -7.88. The company shows no signs of financial improvement or growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Wall Street analysts forecast NVNO stock price to rise
Analyst Rating
0
Wall Street analysts forecast NVNO stock price to rise
Buy
Hold
Sell
0
Current: 10.785
sliders
Low
0
Averages
0
High
0
0
Current: 10.785
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch